NCT04872842已完成不适用
Establishment of Online Registration Platform for Unruptured Intracranial Aneurysms Based on 100 Regional Medical Centers in China and Population Follow-up Study
Beijing Tiantan Hospital1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2021年9月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- Aneurysm rupture
研究概览
简要总结
In this study, 20 regional neurosurgery centers across the country will be included, and the study cohort will be constructed on the basis of the IARP-CP cohort.The artificial intelligence platform was used to analyze the clinical, morphological, hemodynamics, aneurysm wall characteristics and other factors of unruptured aneurysms, as well as the relationship between these factors and the risk of aneurysm instability, seek the potential risk factors, and finally establish a multi-dimensional prediction model of rupture risk of intracranial aneurysms.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18-75 years old;
- •At least one unruptured intracranial aneurysm was found by CTA;
- •No relevant symptoms, receiving non-operative and conservative observation treatment;
- •Signing the informed consent.
排除标准
- •Other cerebrovascular structural lesions (such as cerebrovascular malformation and arteriovenous fistula) or craniocerebral tumors;
- •Fusiform or dissecting aneurysms;
- •Traumatic, mycotic and atrial myxoma associated aneurysms;
- •Suffering from systemic connective tissue diseases, such as polycystic kidney disease;
- •Expectant survival of no more than 3 years due to other diseases or poor general conditions;
- •Patients refuse to follow up or cannot communicate with them due to mental diseases;
- •Pregnant women or participating in other aneurysm related studies.
结局指标
主要结局
Aneurysm rupture
时间窗: 2 years
次要结局
- Aneurysm growth(2 years)
研究者
Wang Shuo
Director of Department of Cerebrovascular Neurosurgery
Beijing Tiantan Hospital
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic NeoplasmsChronic Lymphocytic Leukemia (CLL)Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)Waldenström's Macroglobulinemia (WM)NCT06043011iOMEDICO AG2,950
Unknown
不适用
Burst Biologics Spinal Fusion RegistrySpondylitisHerniated DiskSpondylolisthesisDegenerative Disc DiseaseSpinal StenosisNCT03064802Burst Biologics450
进行中（未招募）
不适用
Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS)Percutaneous Coronary InterventionAcute Coronary SyndromeNCT06075368Genoss Co., Ltd.757
Unknown
不适用
The PAH Platform for Deep Phenotyping in Korean SubjectsDeep PhenotypingHeritable Pulmonary Arterial HypertensionPulmonary Arterial HypertensionIdiopathic Pulmonary Arterial HypertensionNCT03933579Gachon University Gil Medical Center500
尚未招募
不适用
Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder CancerBiliary Tract DiseasesGallbladder CancerGallbladder NeoplasmsNCT06276153RenJi Hospital5,000